Allergan Plc (AGN) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Allergan Plc (AGN) - Medical Equipment - Deals and Alliances Profile

Allergan Plc (AGN) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Allergan Plc (AGN) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
115 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Allergan Plc (Allergan), formerly Actavis plc is a specialty pharmaceutical company, which focuses on the development, manufacturing, marketing and distribution of specialty branded, bio-similar, and over-the-counter (OTC) products. It offers products in the areas of ophthalmology, neurosciences and medical aesthetics, dermatology, plastic surgery, central nervous system, gastroenterology, womens health and urology. The company distributes branded pharmaceutical products of its own and third parties through its ANDA Distribution business to independent pharmacies, pharmacy buying groups, pharmacy chains and physicians offices.

Allergan Plc (AGN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of

  
Source:
Document ID
GDME4874D
Industry
Ticker
AGN=IE
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents26
  List of Tables52
  List of Figures71
Allergan Plc, Medical Equipment, Deals By Year, 2010 to YTD 201672
Allergan Plc, Medical Equipment Deals By Type, 2010 to YTD 201691
Allergan Plc, Medical Equipment, Deals By Region, 2010 to YTD 2016101
Allergan Plc, Medical Equipment, Deals By Market, 2010 to YTD 2016111
Allergan Plc, Medical Equipment, Deals Summary, 2010 to YTD 2016124
Allergan Plc, Medical Equipment, Deal Details1672
  Asset Purchase161
    Allergan Acquires Aline Hyaluronic Acid Thread Technology From Aline Aesthetics161
    Allergan Acquires Distribution Business In Turkey For US$36.7 Million171
  Venture Financing181
    Oculeve Raises US$17 Million In Venture Financing181
    AqueSys Raises US$43.6 Million In Series D Financing192
    Anterios Raises US$8.5 Million In Venture Financing212
    Anterios Raises US$4.7 Million In Venture Financing231
    Oculeve Raises US$7.6 Million In Venture Financing241
    Topokine Therapeutics Raises Funds Through Venture Financing251
    Oculeve Raises Additional US$0.2 Million In Venture Financing261
    Uteron Pharma Raises US$10.4 Million In Venture Financing271
    AqueSys Raises US$12 Million In Venture Financing281
    Uteron Pharma Raises US$19 Million In Venture Financing292
    KYTHERA BioPharma Secures US$37.42 Million In Series D Financing Round312
    Anterios Secures US$3.1 Million In Venture Financing331
    Anterios Raises US$2 Million In Venture Financing341
    AqueSys Secures US$35 Million In Series C Financing Round352
    Anterios Raises US$1.5 Million In Venture Financing371
  Private Equity381
    TPG Capital Acquires Aptalis Pharma from Actavis381
    SRIW Invests US$2 Million In Uteron Pharma391
    Saffelberg Invests In Uteron Pharma401
  Partnerships411
    Medicines360 Enters Into Licensing Agreement With Actavis For Intrauterine Device412
    Enzymatica To Enter Into Licensing Agreement With Actavis For ColdZyme Mouth Spray431
    Acton Pharma Enters Into Licensing Agreement With Forest Labs441
    Allergan Development Agreement with SonarMD451
    Syneron Medical and Allergan Enter into Agreement461
    Activaero Enters Into Collaboration With Forest Healthcare471
  Equity Offering481
    Anterios Postpones IPO for up to USD54.6 Million481
    Actavis Raises USD5.06 Billion in Public Offering of Preferred Shares492
    Actavis Raises USD4.18 Billion in Public Offering of Shares512
    Forest Labs Plans Rights Offering Of Common Stock531
  Debt Offering541
    Forest Lab Completes Private Placement Of Notes Due 2019 For US$1.05 Billion541
    Forest Lab Completes Private Placement Of Notes Due 2021 For US$750 Million551
    Forest Labs Completes Private Placement Of Notes Due 2021 For US$1.2 Billion561
    Allergan Completes Public Offering Of Senior Unsecured Notes Due 2020 For US$650 Million572
  Asset Transactions591
    Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million592
  Acquisition611
    Allergan to Acquire Tobira Therapeutics in Tender Offer613
    Allergan and Pfizer Terminate USD160 Billion Deal643
    Allergan Acquires AqueSys671
    Allergan Acquires Northwood Medical681
    Allergan Acquires Oculeve691
    Actavis Acquires Allergan for USD70.5 Billion702
    Actavis Completes Acquisition of Forest Labs for USD28 Billion722
    Forest Lab Completes Acquisition Of Aptalis Pharma From TPG Capital For US$2.9 Billion742
    AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion761
    Actavis Completes Acquisition Of Remaining 26.7% Stake In Zdravlje For Up To US$9.1 Million771
    Watson Pharma Acquires Uteron Pharma, Women's Health Company, For Up To US$305 Million782
    SkinMedica Acquires Colorescience, Maker Of Skincare Products801
    Allergan Acquires Precision Light For US$17.9 Million811
    Allergan Completes Acquisition Of Alacer Biomedical821
    Forest Labs Completes Acquisition Of Clinical Data833
    Allergan Completes Acquisition Of Serica Technologies862
Allergan Plc - Key Competitors881
Key Employees892
Locations And Subsidiaries919
  Head Office911
  Other Locations &Subsidiaries919
Recent Developments1001
Strategy And Business Planning1001
Aug 09, 2016: EDA Board Acts to Encourage Global Pharmaceutical Company Allergan to Expand in New Jersey1001
Oct 02, 2015: Allergan and Humana Announce Research Partnership to Improve Health Outcomes1011
Financial Announcements1021
Aug 08, 2016: Allergan Reports Strong Second Quarter 2016 Continuing Operations Performance with Net Revenues of $3.7 Billion1024
May 10, 2016: Allergan Reports Strong First Quarter 2016 Continuing Operations Performance with 48% Increase in Net Revenue to $3.8 Billion and 15% Growth in Non-GAAP Diluted EPS to $3.041063
Corporate Communications1091
Feb 08, 2016: Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction1091
Product News1101
Mar 03, 2016: Allergan Launches Bold Access To LILETTA (levonorgestrel-releasing intrauterine system)1101
Apr 28, 2015: Actavis and Medicines360 Announce Publication of ACCESS IUS Efficacy and Safety Study of LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 mg in Contraception1111
Other Significant Developments1121
Oct 13, 2016: Allergan Partners with SonarMD to Develop Innovative IBS-D Patient Engagement Platform for Better Identification and Care of IBS-D Patients1121
Oct 05, 2016: New Study Showcases Economic Impact of Allergan's Operations on New Jersey Economy1132
Appendix1151
  Methodology1151
  About GlobalData1151
  Contact Us1151
  Disclaimer1151

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Allergan Plc (AGN) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 03, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Allergan-Plc-AGN-Medical-Equipment-Deals-and-Alliances-Profile-2148-22593>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Allergan Plc (AGN) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 03, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Allergan-Plc-AGN-Medical-Equipment-Deals-and-Alliances-Profile-2148-22593>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research